Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients Blayney, D., Ogenstad, S., Shi, Y., Zhang, Q., Du, L., Huang, L., Mohanlal, R. ELSEVIER SCIENCE INC. 2018: S461
View details for DOI 10.1016/j.jtho.2018.08.562
View details for Web of Science ID 000454014501196